Immunomedics, Inc.
300 American Road
Morris Plains
New Jersey
07950-2450
United States
Tel: 201-605-8200
Fax: 973-605-8282
Website: http://www.immunomedics.com/
479 articles about Immunomedics, Inc.
-
Immunomedics, Inc. Announces Third Quarter Fiscal 2006 Results
5/11/2006
-
UCB Group And Immunomedics, Inc. Announce Worldwide Development Collaboration And License Agreement For Epratuzumab; Immunomedics To Receive Initial Cash Payments Totaling US $38 Million
5/10/2006
-
The Day In Review: Immunomedics, Inc. Sells Cancer Drug For $183 Million
5/10/2006
-
Immunomedics, Inc. And IBC Pharmaceuticals, Inc. Report On A Novel Protein Engineering Platform Technology
4/25/2006
-
Immunomedics, Inc. Release: Epratuzumab For Immunotherapy Of Lupus Results Published
4/24/2006
-
Immunomedics, Inc. Announces Second Quarter Fiscal 2006 Results
2/15/2006
-
Immunomedics, Inc. Release: New Diagnostic Assay For Pancreatic Cancer Reported In Journal Of Clinical Oncology
12/16/2005
-
Immunomedics, Inc. Reports Preclinical Results On New Therapeutic
12/15/2005
-
Immunomedics, Inc. Shares Rise On Pending Deal
12/14/2005
-
Immunomedics, Inc. Reports Humanized Anti-CD20 Antibody Appears Safe And Active In Non-Hodgkin's Lymphoma
12/12/2005
-
Immunomedics, Inc. Reports Updated Clinical Results Of Epratuzmab-Rituximab Combination In Lymphoma
12/9/2005
-
Immunomedics, Inc. Announces Outcome Of 2005 Annual Meeting Of Shareholders
12/7/2005
-
Immunomedics, Inc. Describes Alleviate Trials Design
11/28/2005
-
Immunomedics, Inc. Reports Updated Clinical Results For Epratuzumab In Sjogren's Syndrome At The 2005 ACR/ARHP Annual Scientific Meeting
11/15/2005
-
Immunomedics, Inc. Announces First Quarter Fiscal 2006 Results
11/8/2005
-
Immunomedics, Inc. To Present At Rodman & Renshaw Techvest 7th Annual Healthcare Conference
11/3/2005
-
The Day In Review: Biotech Slinks Into Closing Bell
3/29/2005
-
Centient Investor Release: Biggest Biotech Winners And Losers During Q3
10/13/2004
-
Immunomedics, Inc. To Present At The 22nd Annual JP Morgan Healthcare Conference
1/7/2004